Bookings are now open for the Cambridge Festival which will take place from 30 March to 10 April, with hundreds of free events and activities for everyone.
Professor Charlotte Coles is to lead an international multidisciplinary team aiming to influence global policy and improve the lives of people at risk of, and living with, breast cancer.
Researchers from the Mark Foundation Institute for Integrated Cancer Medicine discuss how artificial intelligence is making it easier for doctors to diagnose and treat cancer.
Founder and CEO of two biotech companies, a UKRI Innovation Scholar and researcher in the Department of Clinical Neurosciences with two PhDs under her belt, Dr Gita Khalili Moghaddam explains her inspiration.
Researchers have explored the cellular changes that occur in human mammary tissue in lactating and non-lactating women, offering insight into the relationship between pregnancy, lactation and breast cancer.
Experts at the Cancer Research UK Cambridge Centre will receive around £22.5 million over the next five years for their ground-breaking work, as part of the development of a unique chain of cutting-edge research hubs around the UK.
Faulty versions of the BRCA1 and BRCA2 genes are well known to increase the risk of breast cancer in men and women, and in ovarian cancer. Now BRCA1 and BRCA2 have been linked to several other cancers, including those that affect men.